XML 52 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Cash flows from operating activities:      
Net income $ 119,564 $ 97,201 $ 75,725
Adjustments to reconcile net income to net cash provided by operating activities:      
Stock-based compensation 17,434 11,404 8,271
Tax benefit from stock based compensation (4,608) (4,154) (4,718)
Depreciation and amortization 12,642 11,060 9,999
Loss on disposal of fixed assets 250 726 543
Impairment charges 5,932 0 0
Deferred taxes 1,528 1,452 (798)
Provision for doubtful accounts and chargebacks 4,218 2,961 1,576
Accrued interest on note receivable – related party 509 (241) (281)
Deferred rent expense 1,538 (357) 423
Loss (gain) on sale of marketable securities (2,110) (1,254) (29)
Changes in:      
Accounts receivable 19,669 (16,543) (8,266)
Due from factor (35,670) (9,336) (4,985)
Inventories (1,819) (9,210) (8,804)
Prepaid expenses, prepaid taxes, deposits and other 1,557 (2,068) (4,420)
Accounts payable and accrued expenses 11,956 (7,551) 19,572
Accrued incentive compensation (9,163) 964 3,603
Other liabilities (86) (86) (538)
Net cash provided by operating activities 143,341 74,968 86,873
Cash flows from investing activities:      
Purchases of property and equipment (20,102) (15,477) (3,424)
Purchases of marketable securities (63,822) (17,968) (72,663)
Purchase of notes receivable (1,562) 0 (7,004)
Payment of contingent liability (22,867) (4,151) (1,628)
Maturity/sale of marketable securities 46,447 67,885 30,092
Refundable cash acquired from seller 0 12,004 0
Acquisitions (29,367) (89,730) (40,602)
Net cash used in investing activities (91,273) (47,437) (95,229)
Cash flows from financing activities:      
Proceeds from exercise of stock options 9,271 4,994 5,082
Tax benefit from the exercise of options 4,608 4,154 4,718
Common stock purchased for treasury 0 0 (4,559)
Net cash provided by financing activities 13,879 9,148 5,241
Net decrease in cash and cash equivalents 65,947 36,679 (3,115)
Cash and cash equivalents – beginning of period 102,830 66,151 69,266
Cash and cash equivalents – end of period 168,777 102,830 66,151
Supplemental disclosures of cash flow information:      
Interest 49 51 4
Income taxes 52,711 59,633 42,651
Dividend forfeitures related to restricted stock $ 0 $ 0 $ (2)